Jacob Cynamon, MD, Brings Medical Advancements to Montefiore Hospital

    SUFFERN, NY, December 15, 2014 /24-7PressRelease/ -- Dr. Jacob Cynamon has been recognized for showing dedication, leadership and excellence in interventional radiology.

Dr. Cynamon is Board Certified in Radiology and in the sub-specialty of Vascular & Interventional Radiology. Dr. Cynamon was named a Top Doctor in New York Magazine's fifth and tenth anniversary editions. He has also been named one of the New York Metro Area's Top Doctors on six different occasions, and was recognized with Patients' Choice and Castle Connolly Top Doctor awards. He is one of America's leading experts on Abdominal Aortic Aneurysms, Iliac Aneurysms, Peripheral Arterial Occlusive Diseases, Venous Disease, Dialysis Grafts and Fistulae Management. His current interests are helping patients with uterine fibroids and cancer patients using minimally invasive techniques. He is committed to addressing difficult medical problems and finding better solutions. In addition to Dr. Cynamon being the Section Chief at Montefiore for the past 15 years, he continues to be the fellowship program director. The trainees all leave the program with a sense of accomplishment and a drive to continue learning and establishing themselves as leaders in their field.

Dr. Cynamon began his career in health care more than three decades ago after earning his medical degree from Albert Einstein College of Medicine and completing his fellowship in Interventional Radiology at New York Hospital - Cornell Medical Center under the direction of Dr. Thomas A. Sos. Dr. Cynamon then accepted a position at Montefiore Medical Center, the University Hospital for Albert Einstein College of Medicine, where he remains today.

Dr. Cynamon was the first person to perform a Transjugular Intrahepatic Portosystemic Shunt (TIPS) procedure at Montefiore. He continues to pioneer new procedures and conduct interventional radiology and vascular disease research. Dr. Cynamon has written many peer reviewed papers. He described the very popular "Lyse and Wait" procedure for declotting thrombosed dialysis grafts. He also published one of the first reports of the Power Pulse Spray technique for the management of DVT. He is the lead author or contributor to over 50 peer reviewed articles, multiple book chapters and solicited reviews. He is a speaker at many international symposiums, including Interventional Radiology, Vascular Surgery, Interventional Cardiology and Nephrology meetings. He is currently involved in bringing Prostate Artery Embolization to Montefiore as part of a research study that will hopefully lead to FDA approval. He has published and presented on the ability to visualize Drug Eluting Beads on CT immediately post embolization. This was initially not recognized, but now is considered obvious.

In 1992 Dr. Cynamon established a symposium, held annually in NYC, to educate practicing interventional radiologists and trainees. Now in its 22nd year, the AIMsymposium remains an important yearly educational experience.

Dr. Cynamon along with Dr. Frank Veith, Dr. Michael Marin, Dr. Juan Parodi and Dr. Claudio Schonholtz performed the first endovascular AAA repair in the United States. This occurred immediately after Dr. Parodi attended the Vascular Surgery and Interventional Radiology Symposiums in NY. Endovascular procedures have continued to evolve. Many of the new techniques were described by Dr. Cynamon and his colleagues in publications and at the NY Vascular or IR meetings.

Key influential figures in Dr. Cynamon's career include Dr. Seymour Sprayregen, the Chief of IR during his residency and one of the founding members of the SIR, Dr. Thomas A. Sos, his Fellowship Director, Dr. Frank Veith, Chief of Vascular Surgery at Montefiore, and Dr. Barry Katzen, who asked him to speak at ISET twenty three years ago and has remained a great influence in his career.

Dr. Cynamon is a member of the American Board of Radiology and the Society of Interventional Radiology. Looking ahead, he plans to continue to work on challenging cases, further build the division and help patients.

# # #